Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139.

Abstract:

:Endothelin-1 (ET-1) is believed to have a role in the pathogenesis of pulmonary hypertension, and ET antagonists may therefore be useful in the treatment of the disease. Here we have characterized ET receptors and ligands in human pulmonary tissues. Autoradiography showed ETA receptors located in resistance and conduit arteries and ETB receptors present in airway smooth muscle. Competition binding studies in human pulmonary artery (HPA) showed a predominance of the ETA subtype (90%). Bosentan (Ro470203) (Kd ETA = 12.5 nM, Kd ETB = 1.1 microM), SB209670 (Kd ETA = 14.3 nM, Kd ETB = 5.0 microM), and 97-139 (Kd ETA = 5.3 nM, Kd ETB = 19.6 microM) labeled ETA receptors with higher affinity than BMS182874 (50% [125I]ET-1 inhibition at 1 microM). Sarafotoxin S6c labeled ETB receptors with high affinity (Kd ETA = 0.16 microM, Kd ETB = 2.7 nM), whereas BQ788 competed with low affinity for [125I]ET-1 binding sites (Kd = 1.0 microM). This study indicates that an ETA-selective antagonist may be useful in reversing vasoconstriction associated with pulmonary hypertension without affecting ETB-mediated contractile effects in airway smooth muscle or ETB-mediated release of endothelium-derived vasodilators.

journal_name

J Cardiovasc Pharmacol

authors

Russell FD,Davenport AP

subject

Has Abstract

pub_date

1995-01-01 00:00:00

pages

S346-7

eissn

0160-2446

issn

1533-4023

journal_volume

26 Suppl 3

pub_type

杂志文章
  • Therapeutic considerations in applying rate control therapy for atrial fibrillation.

    abstract::The therapeutic strategy of heart rate control for atrial fibrillation (AF) is undergoing a renaissance since several recent randomized trials demonstrated clear advantages over the rhythm control for many patients. Heart rate control for AF is hampered, however, by a dearth of information relating target heart rates ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/FJC.0b013e31816d5f49

    authors: Wyse DG

    更新日期:2008-07-01 00:00:00

  • High-fat diet alters K+-currents in porcine coronary arteries and adenosine sensitivity during metabolic inhibition.

    abstract::Coronary arteries from animals on normal diets (ND) exhibit well-maintained responses to dilators under ischemic conditions. The reported altered metabolic requirements and K+-currents in blood vessels from hypercholesterolemic animals fed high-fat diets (HF) led us to hypothesize that under metabolically depressed co...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200404000-00004

    authors: Franke R,Yang Y,Rubin LJ,Magliola L,Jones AW

    更新日期:2004-04-01 00:00:00

  • Serotonin and Raynaud's phenomenon.

    abstract::No single pathophysiologic mechanism explains adequately cold-induced vasospasm in all forms of Raynaud's phenomenon. Local serotonin release from activated platelets is a contributory element in those disorders typified by structural arterial change, e.g., systemic sclerosis (scleroderma). Selective antagonism of S2-...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章,评审

    doi:

    authors: Seibold JR

    更新日期:1985-01-01 00:00:00

  • The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids.

    abstract::The possible relevance of intrinsic sympathomimetic activity (ISA) for beta-blocker-induced changes in plasma lipids was investigated by reviewing the literature and analyzing the results separately for nonselective beta-blockers, beta 1-selective beta-blockers, and those possessing ISA. It was confirmed that with the...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/00005344-198300051-00008

    authors: van Brummelen P

    更新日期:1983-01-01 00:00:00

  • In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.

    abstract::Various in vitro and in vivo techniques were used to evaluate the cardiovascular actions of MDL 19205, a new cardiotonic agent. In the anesthetized dog, intravenous administration of MDL 19205 (0.1-1 mg/kg) produced marked increases in cardiac contractile force which were accompanied by small increases in heart rate a...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Roebel LE,Dage RC,Cheng HC,Woodward JK

    更新日期:1984-01-01 00:00:00

  • Endothelium-dependent, vasopressin-induced contractions in rabbit renal arteries.

    abstract:OBJECTIVES:To identify and quantify the stimulatory and inhibitory activity of endothelial factors on Arginine vasopressin (AVP)-induced contractions. METHODS:In a standard organ bath set-up for isometric force recording, rabbit isolated renal artery rings were exposed to cumulative concentrations of AVP. Experiments ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200312000-00002

    authors: Streefkerk JO,Pfaffendorf M,van Zwieten PA

    更新日期:2003-12-01 00:00:00

  • Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking.

    abstract::The signaling impact of a human beta1-adrenergic receptor (beta1 AR) polymorphism at residue 49 of the aminoterminus (Ser-to-Gly substitution) was studied by recombinantly expressing each receptor. The two receptors displayed identical agonist and antagonist binding affinities. Furthermore, basal and agonist-stimulate...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-200202000-00001

    authors: Rathz DA,Brown KM,Kramer LA,Liggett SB

    更新日期:2002-02-01 00:00:00

  • Cardioprotective Effects of Atorvastatin Are Mediated Through PPARγ in Paraquat-Exposed Rats.

    abstract:BACKGROUND:Paraquat poisoning is one of leading intoxication worldwide without an effective antidote and treatment protocol. Among the other organs, cardiotoxicity of paraquat has been frequently reported. AIM:The protective effects of atorvastatin (STN) on paraquat-induced cardiotoxicity and the role of peroxisome pr...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/FJC.0000000000000731

    authors: Malekinejad M,Masoumi Verki M,Khoramjouy M,Alenabi A,Hallaj-Salahipour M,Malekinejad H

    更新日期:2019-11-01 00:00:00

  • Combination therapy of hypertension with beta-adrenoceptor blockers and the calcium channel antagonist nitrendipine.

    abstract::The combination of a beta-adrenoceptor-blocking drug with the dihydropyridine calcium channel antagonist, nitrendipine, has particular therapeutic advantages in the management of hypertension. The beta-blocker reduces any reflex increases in sympathetic nervous system and renin-angiotensin system activity that result ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,评审

    doi:10.1097/00005344-198806124-00015

    authors: Mac Carthy EP

    更新日期:1988-01-01 00:00:00

  • Carvedilol improves uptake-1 in patients with systolic congestive heart failure.

    abstract:BACKGROUND:The sympathetic nervous system (SNS) of the whole body, including cardiac sympathetic nerves, is activated in patients with severe congestive systolic heart failure (CHF). Carvedilol can improve clinical status in such patients. This study aimed to determine how carvedilol acts on the SNS to improve CHF. ME...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1097/FJC.0b013e31823a94a2

    authors: Machida M,Takechi S,Fujimoto T,Kakinoki S,Nomura A

    更新日期:2012-02-01 00:00:00

  • Hemodynamic response to oxygen administration in chronic heart failure: role of chemoreflexes.

    abstract::The aim of this study was to assess whether arterial chemoreceptors are activated in chronic heart failure and to appreciate whether this activation is related to the degree of cardiac dysfunction. We examined whether administration of pure oxygen for 30 min to 35 patients with chronic heart failure was followed by he...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00005344-199901000-00022

    authors: Saadjian A,Paganelli F,Levy S

    更新日期:1999-01-01 00:00:00

  • Endothelin-induced activation of phosphoinositide turnover, calcium mobilization, and transmitter release in cultured neurons and neurally related cell types.

    abstract::Endothelin (ET)-related peptides robustly stimulated [3H]-inositol phosphate (IP) formation in cultured cerebellar granule cells, astrocytes, and C6 glioma cells. Their agonist selectivities were ET-1 = ET-2 greater than or equal to sarafotoxin S6b greater than ET-3 greater than big ET-1 for granule cells and ET-1 gre...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Chuang DM,Lin WW,Lee CY

    更新日期:1991-01-01 00:00:00

  • Sympathoinhibitory effects of clonidine are transmitted by the caudal ventrolateral medulla in cats.

    abstract::We examined mechanisms of the central sympathoinhibitory actions of systemically administered clonidine in anesthetized cats. To avoid influences of sympathetic chemo- and baroreflexes, the animals were deafferentated by cutting the carotid sinus and vagal nerves bilaterally. Intravenous (i.v.) injections of clonidine...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199904000-00002

    authors: Seller H,Czachurski J,Zanzinger J

    更新日期:1999-04-01 00:00:00

  • Effects of temocapril and olmesartan on myocardial sympathetic nervous activity and fatty acid metabolism in rats with chronic beta-adrenergic stimulation.

    abstract::We investigated the effects of an angiotensin-converting enzyme inhibitor (temocapril) and an angiotensin II type 1 receptor blocker (olmesartan) on changes in myocardial sympathetic nervous activity, fatty acid metabolism and myocardial blood flow using 131I-meta-iodobenzylguanidine, 125I-beta-methyl-iodophenyl penta...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Ido A,Hasebe N,Takeuchi T,Kikuchi K

    更新日期:2003-01-01 00:00:00

  • Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.

    abstract::Results of previous studies indicate that monophosphoryl lipid A (MLA) reduces myocardial infarct size when administered 24 but not 1 h before a prolonged period of regional ischemia in dogs and rabbits. This cardioprotective effect of MLA could be reversed by the administration of the adenosine triphosphate (ATP)-sen...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199807000-00008

    authors: Elliott GT,Mei DA,Gross GJ

    更新日期:1998-07-01 00:00:00

  • Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.

    abstract::We compared the effects of angiotensin II (AII), enalapril, and losartan given by acute intravenous (i.v.) injection, on cardiac baroreflex sensitivity in two groups of conscious normotensive rabbits bred for high gain [> 5 beats/min/mm Hg] (group I) and low gain [< 4 beats/min/mm Hg] (group II) of the mean arterial b...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199503000-00024

    authors: Weinstock M,Gorodetsky E

    更新日期:1995-03-01 00:00:00

  • The pathway-selective estrogen receptor ligand WAY-169916 displays differential activity in ischemia-reperfusion injury models.

    abstract::We previously reported on the development of a pathway-selective estrogen receptor (ER) ligand, WAY-169916, that has ER-dependent antiinflammatory activity and is devoid of classic ER transcriptional activity. In the current study, WAY-169916 and 17beta-estradiol (17beta-E2) were evaluated for protective activity in m...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/01.fjc.0000211793.60528.f7

    authors: Harnish DC,Liu X,Kenney T,Winneker RC,Chadwick C,Friedrichs GS,Kilbourne EJ

    更新日期:2006-06-01 00:00:00

  • Central and peripheral alpha-adrenoceptor number and responsiveness after sinoaortic denervation in the rabbit.

    abstract::The effects of bilateral sinoaortic denervation were examined in rabbits in vivo and in vitro. In the in vivo studies the effects of intravenous administration of the alpha-adrenoceptor agonists phenylephrine and guanabenz and the antagonists prazosin and phentolamine on mean arterial pressure, heart rate, and plasma ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-198207000-00007

    authors: Berthelot A,Hamilton CA,Petty MA,Reid JL

    更新日期:1982-07-01 00:00:00

  • Ambulatory and home blood pressure normality: the Pamela Study.

    abstract::Ambulatory blood pressure monitoring (ABPM) is increasingly used in the clinical evaluation of hypertension. However, a number of limitations restrict its routine use. One of the limitations is a lack of definite conclusions about ambulatory blood pressure normality, because of the shortcomings of previous studies on ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1097/00005344-199423005-00004

    authors: Sega G,Bravi C,Cesana G,Valagussa F,Mancia G,Zanchetti A

    更新日期:1994-01-01 00:00:00

  • Effects of ramipril on arterial hemodynamics.

    abstract::The acute and chronic arterial effects of the angiotensin-converting enzyme (ACE) inhibitor ramipril were studied in hypertensive patients. Hemodynamic and biological parameters were measured 3 h after the first dose of 5 mg of ramipril, and then again after 4 weeks of treatment, 3 and 24 h after drug administration. ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Benetos A,Vasmant D,Thiéry P,Safar M

    更新日期:1991-01-01 00:00:00

  • Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents.

    abstract::We studied the acute intravenous (i.v.) effects of the antiarrhythmic agents ibutilide, sematilide, lidocaine, and encainide in a canine Y-shaped right atrial incision model of atrial flutter. After baseline determination of atrial effective refractory period (AERP), sustained atrial flutter (AFL) was initiated by atr...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199504000-00005

    authors: Buchanan LV,Kabell G,Gibson JK

    更新日期:1995-04-01 00:00:00

  • Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.

    abstract::An open randomized hospital study conducted in 169 centers in France compared the blood pressure response to the first 36 h of treatment with perindopril (PER), 2 mg once daily, with that to captopril (CAP), 6.25 mg t.i.d., in 725 patients (mean age, 70 years; men, 67%) with echocardiographic left ventricular systolic...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1097/00005344-199906000-00017

    authors: Haïat R,Piot O,Gallois H,Hanania G

    更新日期:1999-06-01 00:00:00

  • Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.

    abstract::We examined the influence of the new angiotensin-converting enzyme inhibitor (ACEI) fosinopril on function and perfusion of the diabetic rat heart. Streptozotocin-diabetic rats (60 mg/kg body weight) were treated with fosinopril (10 mg/kg body weight/day) for 4 months. Cardiac performance was analyzed in the isolated ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199601000-00011

    authors: Rösen P,Rump AF,Rösen R

    更新日期:1996-01-01 00:00:00

  • Characterization of endothelin receptors in isolated, perfused human spleen.

    abstract::At present, there is no information on endothelin-1 (ET-1)-mediated vascular effects in the human spleen. The objectives of this study were to investigate the in vitro vascular responses to ET-1 using pharmacologic probes (selective ET receptor agonists/antagonists) and to characterize the ET receptor population in th...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/00005344-199800001-00159

    authors: Faro R,Grassi-Kassise DM,Boin I,Withrington PG,Opgenorth TJ,Ferraz JG,Antunes E,de Nucci G

    更新日期:1998-01-01 00:00:00

  • Expression of endothelin and ETB receptors in the megakaryoblastic MEG-01 cell line.

    abstract::The presence of endothelin (ET) receptors and the nature of the subtype and expression of ET were investigated in the human megakaryoblastic cell line MEG-01. By the RT-PCR procedure, we have shown that both ETA and ETB receptor subtype mRNAs are expressed in the cells. However, binding experiments have shown that the...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Hamroun D,Mathieu MN,Clain E,Germani E,Laliberté MF,Laliberté F,Chevillard C

    更新日期:1995-01-01 00:00:00

  • Kinin signal transduction: role of phosphoinositides and eicosanoids.

    abstract::Kinins elicit prostaglandin and inositol phosphate production in 3T3 fibroblasts through stimulation of B2 receptors. Prostaglandin synthesis is maximum by 5 min, whereas inositol phosphate production continues for longer than 30 min. Prostaglandin synthesis is stimulated by phospholipase A2, which releases arachidona...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Burch RM

    更新日期:1990-01-01 00:00:00

  • International cooperative study on the relationship between dietary factors and blood pressure: a report from the Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study.

    abstract::To investigate the epidemiological relationship of dietary factors to blood pressure (BP) and major cardiovascular diseases, we carried out the International Cooperative Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study, which so far involves 45 centers in 20 countries. From each population, 100 men an...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Yamori Y,Nara Y,Mizushima S,Mano M,Sawamura M,Kihara M,Horie R

    更新日期:1990-01-01 00:00:00

  • Diminished responses to nifedipine imply severe end-organ damage in spontaneously hypertensive rats.

    abstract::This study was designed to investigate the effect of end-organ damage (EOD), the initial blood pressure levels, and baroreflex sensitivity (BRS) on the blood pressure-lowering effect of nifedipine in spontaneously hypertensive rats (SHRs). Nifedipine was intravenously administered at a dose of 1 mg/kg. BP was continuo...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:10.1097/01.fjc.0000189077.71730.b8

    authors: Lu LH,Xie HH,Cai GJ,Shen FM,Su DF

    更新日期:2005-12-01 00:00:00

  • Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.

    abstract:AIMS:To determine whether short-term treatment with trimetazidine (TMZ), an antiischemic agent that directly inhibits fatty acid oxidation and results in stimulation of glucose oxidation, may improve myocardial perfusion and left ventricular systolic function in diabetic patients with ischemic cardiomyopathy. METHODS ...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1097/FJC.0b013e31817bdd66

    authors: Belardinelli R,Cianci G,Gigli M,Mazzanti M,Lacalaprice F

    更新日期:2008-06-01 00:00:00

  • Prazosin in hypertension with heart failure.

    abstract::Prazosin, in daily doses of 6--16 mg, was used along with furosemide and polythiazide in 11 hypertensive heart failure patients. Average supine and standing blood pressures were reduced from 180/108 and 171/106 to 130/84 and 135/86, respectively. Average heart rate decreased from 83 to 73 supine and from 84 to 75 stan...

    journal_title:Journal of cardiovascular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Antani JA

    更新日期:1979-11-01 00:00:00